VideoHIVLong-term toxicities of commonly prescribed first line regimens, a 10 – 20 year horizon | José Arribas, MDView Video
VideoHIVIntegrating Science Into The Clinic: Current and Future Use of Integrase Inhibitors | Marta Boffito, MD, PhD, FRCPView Video
VideoHIVCaring for the aging HIV infected patient: meeting the challenge | Giovanni Guaraldi, MDView Video
VideoHIVExamples of missed opportunities in avoiding long term toxicities and comorbidities | Yazdan Yazdanpanah, MD, PhDView Video